These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33531755)

  • 1. Evaluation of MR Visual Rating Scales in Major Forms of Dementia.
    Kaushik S; Vani K; Chumber S; Anand KS; Dhamija RK
    J Neurosci Rural Pract; 2021 Jan; 12(1):16-23. PubMed ID: 33531755
    [No Abstract]   [Full Text] [Related]  

  • 2. Associations of multiple visual rating scales based on structural magnetic resonance imaging with disease severity and cerebrospinal fluid biomarkers in patients with Alzheimer's disease.
    Wan MD; Liu H; Liu XX; Zhang WW; Xiao XW; Zhang SZ; Jiang YL; Zhou H; Liao XX; Zhou YF; Tang BS; Wang JL; Guo JF; Jiao B; Shen L
    Front Aging Neurosci; 2022; 14():906519. PubMed ID: 35966797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of Cortical Atrophy and White Matter Lesions Between Dementia With Lewy Bodies and Alzheimer's Disease: A Case-Control Study.
    Zhu H; Lu H; Wang F; Liu S; Shi Z; Gan J; Du X; Yang Y; Li D; Wang L; Ji Y
    Front Neurol; 2021; 12():779344. PubMed ID: 35087466
    [No Abstract]   [Full Text] [Related]  

  • 4. A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer's disease in a Chinese population.
    Wei M; Shi J; Ni J; Zhang X; Li T; Chen Z; Zhou M; Zhang L; Tan Z; Wang Y; Tian J
    BMC Geriatr; 2019 Feb; 19(1):59. PubMed ID: 30819102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatically computed rating scales from MRI for patients with cognitive disorders.
    Koikkalainen JR; Rhodius-Meester HFM; Frederiksen KS; Bruun M; Hasselbalch SG; Baroni M; Mecocci P; Vanninen R; Remes A; Soininen H; van Gils M; van der Flier WM; Scheltens P; Barkhof F; Erkinjuntti T; Lötjönen JMP;
    Eur Radiol; 2019 Sep; 29(9):4937-4947. PubMed ID: 30796570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.
    Ferreira D; Cavallin L; Larsson EM; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2015 Sep; 278(3):277-90. PubMed ID: 25752192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies.
    Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; O'Brien JT
    Neurology; 1999 Apr; 52(6):1153-8. PubMed ID: 10214736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI Visual Ratings of Brain Atrophy and White Matter Hyperintensities across the Spectrum of Cognitive Decline Are Differently Affected by Age and Diagnosis.
    Rhodius-Meester HFM; Benedictus MR; Wattjes MP; Barkhof F; Scheltens P; Muller M; van der Flier WM
    Front Aging Neurosci; 2017; 9():117. PubMed ID: 28536518
    [No Abstract]   [Full Text] [Related]  

  • 9. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment.
    Korf ES; Wahlund LO; Visser PJ; Scheltens P
    Neurology; 2004 Jul; 63(1):94-100. PubMed ID: 15249617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of muscle strength with cognitive function and medial temporal lobe atrophy in patients with mild to moderate Alzheimer's disease].
    Liu SW; Li M; Zhu JT; Zhang YC; Wu YH; Liu CF; Hu H
    Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(35):2786-2792. PubMed ID: 36124351
    [No Abstract]   [Full Text] [Related]  

  • 11. Episodic memory and the medial temporal lobe: not all it seems. Evidence from the temporal variants of frontotemporal dementia.
    Pleizier CM; van der Vlies AE; Koedam E; Koene T; Barkhof F; van der Flier WM; Scheltens P; Pijnenburg Y
    J Neurol Neurosurg Psychiatry; 2012 Dec; 83(12):1145-8. PubMed ID: 22933816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of Frontal Atrophy and CSF Tau Levels With Neuropsychiatric Symptoms in Patients With Cognitive Impairment: A Memory Clinic Experience.
    Cotta Ramusino M; Perini G; Vaghi G; Dal Fabbro B; Capelli M; Picascia M; Franciotta D; Farina L; Ballante E; Costa A
    Front Aging Neurosci; 2021; 13():595758. PubMed ID: 33746732
    [No Abstract]   [Full Text] [Related]  

  • 13. Medial temporal lobe atrophy in vascular dementia: visual temporal lobe rating scale.
    Cho H; Kwon JH; Seo HJ
    Arch Gerontol Geriatr; 2009; 48(3):415-8. PubMed ID: 18468705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    Hsu JL; Lee WJ; Liao YC; Lirng JF; Wang SJ; Fuh JL
    PLoS One; 2015; 10(9):e0137121. PubMed ID: 26372372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study.
    Wahlund LO; Julin P; Johansson SE; Scheltens P
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):630-5. PubMed ID: 11032615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging-measured atrophy and its relationship to cognitive functioning in vascular dementia and Alzheimer's disease patients.
    Logue MW; Posner H; Green RC; Moline M; Cupples LA; Lunetta KL; Zou H; Hurt SW; Farrer LA; Decarli C;
    Alzheimers Dement; 2011 Sep; 7(5):493-500. PubMed ID: 21723205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of medial temporal lobe atrophy visual rating scale in detecting Alzheimer's disease: Preliminary study.
    Heo JH; Kim MK; Lee JH; Lee JH
    Ann Indian Acad Neurol; 2013 Jul; 16(3):384-7. PubMed ID: 24101822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and clinical correlation of practical cut-offs for visual rating scales of atrophy: normal aging versus mild cognitive impairment and Alzheimer's disease.
    Vanhoenacker AS; Sneyers B; De Keyzer F; Heye S; Demaerel P
    Acta Neurol Belg; 2017 Sep; 117(3):661-669. PubMed ID: 28397182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining visual rating scales to identify prodromal Alzheimer's disease and Alzheimer's disease dementia in a population from a low and middle-income country.
    Custodio N; Malaga M; Chambergo-Michilot D; Montesinos R; Moron E; Vences MA; Huilca JC; Lira D; Failoc-Rojas VE; Diaz MM
    Front Neurol; 2022; 13():962192. PubMed ID: 36119675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications.
    Ferreira D; Verhagen C; Hernández-Cabrera JA; Cavallin L; Guo CJ; Ekman U; Muehlboeck JS; Simmons A; Barroso J; Wahlund LO; Westman E
    Sci Rep; 2017 Apr; 7():46263. PubMed ID: 28417965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.